We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Kulchaya Sheaya Lender capsules pose a serious risk to your health and should not be taken.
The Therapeutic Goods Administration (TGA) has tested a product labelled Kulchaya Sheaya Lender capsules and found that:
- The Kulchaya Sheaya Lender capsules contain the undeclared substance Fluoxetine.
Fluoxetine is the active ingredient used and marketed for the treatment of depression.
Consumers are advised that Fluoxetine is a prescription-only (S4) medicine in Australia.
The supply of Kulchaya Sheaya Lender capsules containing the undisclosed Fluoxetine is illegal.
Kulchaya Sheaya Lender capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
Information for consumers
- Stop taking Kulchaya Sheaya Lender capsules and take any remaining capsules to your local pharmacy for safe disposal.
- If you have any concerns arising from your use of this product, consult your health care practitioner.
Action the TGA is taking
The TGA is working with the Australian Border Force (ABF) to help stop future shipments of Kulchaya Sheaya Lender capsules from entering Australia.
If these capsules are found at the border by the ABF they will be seized and destroyed.
The TGA is advising consumers to exercise extreme caution when purchasing medicines from unknown overseas Internet sites and has produced a short video on the risks associated with buying medicines and medical devices online. Products purchased over the Internet:
- may contain undisclosed and potentially harmful ingredients
- may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.